Regulatory
Senate passes budget resolution, includes amendment to expand HSAs to cover dietary supplements
February 5th 2021Senators Mike Lee and Tim Scott introduced an amendment during the Senate Budget Resolution hearing that would expand health savings accounts (HSA), health reimbursement arrangements, and flexible spending accounts (FSA) to cover dietary supplements.
AIDP receives patent for multi-ingredient prebiotic formula
February 3rd 2021AIDP, Inc. has secured U.S. patent 10,881,675 B2 on Jan. 5, 2021 for the combination of Actazin, a green or gold kiwi extract powder rich in the digestive enzyme actinidin, with PreticX xylooligosaccharide (XOS), a prebiotic.
Brazil's ANVISA grants Stratum Nutrition, Ayalla novel food approval for NEM brand eggshell membrane
January 29th 2021Stratum Nutrition and Ayalla announced ANVISA, the National Health Surveillance Agency of the Brazilian Ministry of Health, granted “safety and efficacy as a bioactive substance” pre-market approval of NEM brand eggshell membrane.
NSF launches 455 GMP Certification expanding its audit program to cosmetics and OTC drugs
January 22nd 2021The NSF/ANSI 455 GMP standards were designed to strengthen safety, quality, and trust through the supply chain, as well as combine the regulatory requirements with retailer quality requirements, and reduce the number of audits and financial costs associated with audits.
NY State Department of Health proposes new hemp-derived CBD regulation, CRN responds
January 18th 2021The New York State Department of Health recently proposed new cannabinoid hemp regulation which establishes requirements for licensure for extraction and manufacturing, as well as the sale of hemp-derived cannabidiol (CBD) products.
Chemi Nutra granted patent for phosphatidic acid to support muscle mass and strength
December 23rd 2020Chemi Nutra has been granted a new patent (United States Patent 10,869,843) for phosphatidic acid, claiming that its branded Mediator PA can increase muscle mass and strength when accompanied with resistance exercise.
FTC cracks down on unsubstantiated CBD claims
December 22nd 2020FTC is taking action against six companies for allegedly making a wide range of scientifically unsubstantiated claims regarding CBD’s ability to treat serious health conditions such as cancer, heart disease, hypertension, and Alzheimer’s.
KGK Science provides path-to-market strategy for Psyched Wellness novel mushroom extract
December 18th 2020KGK Science has been contracted by Psyched Wellness, a Canadian health supplement company, to provide a regulatory package of services to support the launch of its Amanita muscaria mushroom extract in the U.S. and Canada.
CRN calls for consistent, harmonized CBD regulation between states based on federal frameworks
December 17th 2020The Council for Responsible Nutrition recently submitting comments regarding the Proposed Kentucky Administrative Regulation 902 KAR 45:190, hemp-derived cannabidiol products and labeling requirements.
CRN responds to FDA’s sudden policy change on supplements containing N-acetyl-L-cysteine
December 8th 2020The Council for Responsible Nutrition has responded to FDA regarding recent warning letters from the Agency alleging that N-acetyl-L-cysteine (NAC) is not a dietary supplement, and therefore prohibited from being marketed as such under the Federal Food, Drug, and Cosmetic Act.
BAPP issues revised SOP for irreparably defective articles, opens public comment
December 3rd 2020The Botanical Adulterants Prevention Program (BAPP) issued its revised draft of "Best Practices Contract Language and Standard Operating Procedure (SOP) Templates for the Disposal/Destruction of Irreparably Defective Articles."